Literature DB >> 2741922

Platelet activation during pain crisis in sickle cell anemia patients.

C Beurling-Harbury1, S G Schade.   

Abstract

Platelet activation at sites of enmeshed sickled red cells in the microcirculation may contribute to platelet plug formation and microinfarction in sickle cell anemia. To test this hypothesis platelets from 116 sickle cell anemia patients free of crisis, 32 patients with crisis, 16 convalescents within 1 week of crisis, and 180 normal controls were studied. Platelets store 90% of their ADP in dense secretory granules. During activation ADP is secreted and permanently lost from the cell. This leads to a decrease in cellular ADP concentration and a sharp rise in the ATP/ADP ratio. ATP and ADP were ethanol-extracted from platelet-rich plasma, measured in the luciferase-luciferin assay and expressed in nmoles per 10(8) cells. No adenine nucleotide differences were found in platelets from patients free of crisis compared with normal controls. The ADP concentration of platelets from patients in crisis was significantly lowered, indicating that in vivo platelet secretion of ADP had occurred. Total and released ADP was decreased from 2.69 to 1.66, and from 1.90 to 1.21 respectively, and the total ATP/ADP ratio was increased from 1.85 to 2.84 (P less than 0.001). ADP stores in platelets from convalescents were significantly different from sickle controls (P less than 0.001) but were less abnormal than ADP stores in platelets from crisis patients (P less than 0.01), indicating recovery. Total and released ADP was decreased to 1.97 and 1.31 respectively, and the ATP/ADP ratio was increased to 2.38. Platelets from patients in crisis were able to release their remaining granular ADP in response to thrombin as effectively as normal platelets. Thus significant platelet activation with ADP release occurs during acute sickle pain crisis. This might contribute to platelet plug formation and microvascular obstruction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2741922     DOI: 10.1002/ajh.2830310404

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  8 in total

1.  P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease.

Authors:  Renata Polanowska-Grabowska; Kori Wallace; Joshua J Field; Lanlin Chen; Melissa A Marshall; Robert Figler; Adrian R L Gear; Joel Linden
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

Review 2.  Potential future clinical applications for the GPIIb/IIIa antagonist, abciximab in thrombosis, vascular and oncological indications.

Authors:  S A Cohen; M Trikha; M A Mascelli
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

3.  Woman with Sickle Cell Disease with Current Sigmoid Sinus Thrombosis and History of Inadequate Warfarin Use during a Past Thrombotic Event.

Authors:  Asuman Celikbilek; Mehmet Celikbilek; Alper Bozkurt; Başak Karakurum Göksel; Meliha Tan; Hakan Ozdoğu
Journal:  Case Rep Neurol       Date:  2009-05-16

4.  Morphological and functional platelet abnormalities in Berkeley sickle cell mice.

Authors:  Arun S Shet; Thomas J Hoffmann; Marketa Jirouskova; Christin A Janczak; Jacqueline R M Stevens; Adewole Adamson; Narla Mohandas; Elizabeth A Manci; Therese Cynober; Barry S Coller
Journal:  Blood Cells Mol Dis       Date:  2008-04-18       Impact factor: 3.039

5.  Calpain-1 regulates platelet function in a humanized mouse model of sickle cell disease.

Authors:  Jennifer O Nwankwo; Thomas Gremmel; Anja J Gerrits; Farha J Mithila; Rod R Warburton; Nicholas S Hill; Yunzhe Lu; Lauren J Richey; Joseph A Jakubowski; Andrew L Frelinger; Athar H Chishti
Journal:  Thromb Res       Date:  2017-10-26       Impact factor: 3.944

6.  A phase 1 study of prasugrel in patients with sickle cell disease: pharmacokinetics and effects on ex vivo platelet reactivity.

Authors:  Joseph A Jakubowski; Chunmei Zhou; David S Small; Kenneth J Winters; D Richard Lachno; Andrew L Frelinger; Jo Howard; Timothy G Mant; Stipo Jurcevic; Christopher D Payne
Journal:  Br J Clin Pharmacol       Date:  2013-06       Impact factor: 4.335

7.  Pulmonary platelet thrombi and vascular pathology in acute chest syndrome in patients with sickle cell disease.

Authors:  Ciprian B Anea; Matthew Lyon; Itia A Lee; Joyce N Gonzales; Amidat Adeyemi; Greer Falls; Abdullah Kutlar; Julia E Brittain
Journal:  Am J Hematol       Date:  2016-02       Impact factor: 10.047

8.  CXCR4hi effector neutrophils in sickle cell anemia: potential role for elevated circulating serotonin (5-HT) in CXCR4hi neutrophil polarization.

Authors:  Flavia Garcia; Rafaela Mendonça; Lediana I Miguel; Venina M Dominical; Sara T O Saad; Fernando F Costa; Nicola Conran
Journal:  Sci Rep       Date:  2020-08-31       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.